Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medicenna Therapeutics Corp T.MDNA

Alternate Symbol(s):  MDNAF

Medicenna Therapeutics Corp. is a Canada-based clinical-stage immunotherapy company. The Company's principal business activity is the development and commercialization of interleukin-2 (IL-2), interleukin-4 (IL-4) and interleukin-13 (IL-13) Superkines and Empowered Superkines for the treatment of cancer, inflammation and immune-mediated diseases. Its long-acting IL-2 Superkine, MDNA11, is an IL... see more

TSX:MDNA - Post Discussion

Medicenna Therapeutics Corp > Surprised and grateful that MDNA ran up over 2.00
View:
Post by Galaxym31 on Apr 20, 2024 11:56am

Surprised and grateful that MDNA ran up over 2.00

again thanks a million .
Comment by windymayor1 on Apr 26, 2024 11:09am
Looks like they left $2 in the dust. Next stop margin eligible $3.00! 
Comment by ENEMENEMYNEMO on Apr 26, 2024 3:34pm
RA Capital Management is a frontrunner in evidence-based investing. With a strategic emphasis on healthcare and life sciences entities, this Boston-based firm caters to all stages of company growth, from budding startups to established public corporations. RA Capital isn't merely an investor. The firm stands out with its pioneering TechAtlas division, an entity dedicated to ...more  
Comment by Peladawn on Apr 27, 2024 9:25pm
Beware of this pump and dump.....Enemememem is nothing but a paid shill .....he's over on the ONCY board constantly trashing other posters while his employer shorts the stock....he's pumping here now, so take your profits while you can, because once they're done pumping, they'll short this stock too and leave investors hanging.....don't believe me?....go check out this A-whole& ...more  
Comment by ENEMENEMYNEMO on Apr 28, 2024 8:41am
Someone is angry they missed out!!  MDNA is successful , meanwhile you are pumping a nothing burger that's been looking for success from the same product for 25 years with no success.  Where they have been successful is suckering in investors with false hope draining many of their savings for what 20 clinical trials that went no where!!!
Comment by Peladawn on Apr 29, 2024 7:25pm
Oh really?....please explain how it is that they're successful....lol...is that why they just had to borrow $20 mil?....
Comment by windymayor1 on Apr 30, 2024 1:42pm
Doesn't sound like you understand the biotech sector or equity financing for that matter. 
Comment by Galaxym31 on May 02, 2024 12:00pm
    I dont but I did buy 20 000 shares below .45 
Comment by Tarbaby on Apr 29, 2024 11:32am
Agreed..they wouldnt plunk $20M into just any company. They see the potential of MDNA and must be happy with its results so far. This should be a takeover candidate soon. At $1B ++
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities